JW Pharmaceutical is a South Korean company that focuses on the development of innovative new drugs with new technology. They have a strong pipeline of products such as Livalo, Thrupas, Sigmart, Actemra, etc. Their research areas include cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, rare diseases, and eye diseases.